CareDx, Inc (NasdaqGM:CDNA) agreed to acquire TransChart, LLC on January 8, 2021. This acquisition will expand CareDx's EMR coverage to over 90 centers in total. The transaction is expected to close in January 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.3 USD | -1.45% | +27.00% | +52.50% |
07-10 | Nephron Initiates CareDx at Hold Rating With $15 Price Target | MT |
07-01 | CareDx, Inc(NasdaqGM:CDNA) added to Russell 3000 Growth Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.50% | 955M | |
-33.27% | 9.11B | |
+20.33% | 3.98B | |
+9.96% | 2.5B | |
-8.11% | 1.93B | |
-26.17% | 1.86B | |
+41.83% | 1.23B | |
-6.77% | 715M | |
-18.99% | 237M | |
-12.78% | 167M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx, Inc agreed to acquire TransChart, LLC.